HIGH-DOSE CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, ETOPOSIDE, AND CARBOPLATIN FOLLOWED BY RESCUE WITH AUTOLOGOUS BONE MARROW AND AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH POOR PROGNOSIS BREAST CANCER
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Etoposide
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2010 Biomarkers information updated
- 19 Sep 2005 New trial record.